Schedule 13D ownership disclosure

BioLife Solutions Inc

Common Stock, par value $0.001 per share · CUSIP: 09062W204

Event date: 2025-08-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Casdin Capital, LLCReported CIK 0001534261

    Shares: 6,707,165.00 · Class: 14.0%

  • Casdin Partners Master Fund, L.P.Reported CIK 0001534265

    Shares: 6,707,165.00 · Class: 14.0%

  • Casdin Partners GP, LLCReported CIK 0001534260

    Shares: 6,707,165.00 · Class: 14.0%

  • Eli CasdinReported CIK 0001534264

    Shares: 6,707,165.00 · Class: 14.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-005054
Form type
SCHEDULE 13D/A
Filer
BIOLIFE SOLUTIONS INC
CIK
CIK 834365
Filed
Aug 21, 2025
Reporting period
Aug 15, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub